Immutep’S Efti With Radiotherapy & KEYTRUDA® Meets Primary Endpoint In Phase 2 For Soft Tissue Sarcoma
RefinitivMenos de 1 minuto de lectura
Immutep Ltd 
IMM:
IMMUTEP’S EFTI WITH RADIOTHERAPY & KEYTRUDA® (PEMBROLIZUMAB) MEETS PRIMARY ENDPOINT IN PHASE II FOR SOFT TISSUE SARCOMA
Inicie sesión o cree una cuenta gratuita y permanente para leer esta noticia